These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20568483)

  • 41. Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009.
    Lindsey NP; Staples JE; Jones JF; Sejvar JJ; Griggs A; Iskander J; Miller ER; Fischer M
    Vaccine; 2010 Dec; 29(1):58-64. PubMed ID: 20970488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).
    Schuller E; Klingler A; Dubischar-Kastner K; Dewasthaly S; Müller Z
    Vaccine; 2011 Nov; 29(47):8669-76. PubMed ID: 21907747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
    Bharati K; Rani R; Vrati S
    Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Japanese encephalitis].
    Jackson Y; Chappuis F; Loutan L
    Rev Med Suisse; 2007 May; 3(111):1233-6. PubMed ID: 17585626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Japanese encephalitis and the traveller.
    Bucens M; O'Connor L
    Aust Fam Physician; 1990 Feb; 19(2):163-5. PubMed ID: 2157385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new Japanese encephalitis vaccine (Ixiaro).
    Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.
    Schuller E; Klade CS; Heinz FX; Kollaritsch H; Rendi-Wagner P; Jilma B; Tauber E
    Vaccine; 2008 Nov; 26(48):6151-6. PubMed ID: 18804132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Japanese encephalitis - prevention in travellers.
    Mayer CA; Neilson AA
    Aust Fam Physician; 2010 Jun; 39(6):389-94. PubMed ID: 20628677
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
    Furesz J; Scheifele DW; Palkonyay L
    CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Recent data on the epidemiology of Japanese encephalitis].
    Rodhain F
    Bull Acad Natl Med; 1996; 180(6):1325-37; discussion 1338-40. PubMed ID: 8991613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Aug; 10(4):210-4. PubMed ID: 2805047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Japanese encephalitis vaccine (inactivated, adsorbed) [IXIARO].
    Duggan ST; Plosker GL
    Drugs; 2009; 69(1):115-22. PubMed ID: 19192940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.